chronic
lymphocyt
leukaemia
cll
common
form
leukaemia
western
countri
mainli
affect
elderli
individu
follow
extrem
variabl
cours
surviv
rang
month
decad
avail
treatment
often
induc
diseas
remiss
almost
patient
relaps
consensu
cll
remain
incur
multipl
instanc
diseas
famili
low
incid
among
individu
japanes
origin
includ
migrat
hawaii
suggest
genet
influenc
stronger
environment
factor
pathogenesi
weiss
associ
studi
detect
loci
influenc
cll
risk
sellick
et
al
et
al
slager
et
al
recent
sequenc
studi
address
repertoir
somat
mutat
genet
lesion
diseas
fabbri
et
al
puent
et
al
wang
et
al
quesada
et
al
among
gene
found
recurr
mutat
emerg
predictor
poor
surviv
sportoletti
et
al
fabbri
et
al
puent
et
al
rossi
et
al
wang
et
al
quesada
et
al
sever
studi
start
shed
light
natur
genet
predisposit
cll
howev
none
report
genet
aberr
mutat
delet
trisomi
shown
major
caus
diseas
basi
disord
remain
unknown
sellick
et
al
dighiero
hamblin
sinc
peyton
rou
discoveri
avian
sarcoma
could
transmit
filtrat
follow
discoveri
mammari
tumour
viru
murin
leukaemia
viru
polyoma
viru
least
six
differ
virus
implic
human
cancer
klein
includ
dna
virus
viru
ebv
human
papilloma
viru
hepat
b
viru
human
herp
viru
well
rna
virus
hepat
c
human
adult
cell
leukaemia
viru
htlv
class
rna
tumour
virus
carri
cellular
oncogen
known
play
role
tumour
causat
natur
class
ii
chronic
rna
tumour
virus
carri
oncogen
act
provir
dna
insert
immedi
neighbourhood
cellular
oncogen
felin
murin
avian
leukaemia
virus
belong
categori
htlv
bovin
leukaemia
viru
blv
expand
cell
popul
transactiv
induc
viral
tax
protein
therebi
provid
seed
secondari
cellular
chang
anim
model
cll
enzoot
bovin
leukaemia
ebl
induc
blv
retroviru
belong
deltaretroviru
genu
close
relat
viru
viru
induc
hyper
lymphocytosi
signific
number
anim
caus
aggress
diseas
case
gillet
et
al
despit
suggest
anim
model
littl
research
devot
issu
use
classic
polymeras
chain
reaction
pcr
technolog
known
viru
identifi
case
human
cll
hermouet
et
al
attempt
made
associ
ebv
cll
accumul
data
argu
role
ebv
earli
develop
diseas
would
suggest
possibl
involv
gener
secondari
malign
tsimberid
et
al
dolcetti
carbon
tarrand
et
al
recent
studi
also
address
presenc
merkel
cell
polyomaviru
mcpyv
cll
koljonen
et
al
shuda
et
al
pantulu
et
al
tolstov
et
al
teman
et
al
result
regard
mcpyv
dna
contradictori
show
extrem
low
mcpyv
copi
number
detect
given
high
seropreval
viru
analys
popul
progress
immunodefici
associ
cll
mcpyv
detect
might
like
explain
background
infect
viral
reactiv
immunodefici
koljonen
et
al
shuda
et
al
pantulu
et
al
tolstov
et
al
teman
et
al
recent
year
molecular
techniqu
success
appli
identif
infecti
agent
borna
viru
kaposi
herpesviru
west
nile
viru
sever
acut
respiratori
syndrom
sar
coronaviru
effort
fail
howev
agent
question
truli
novel
suffici
distant
sequenc
relat
agent
allow
hybrid
poorli
express
rna
level
advent
sequenc
combin
bioinformat
analysi
could
pave
way
discoveri
new
infecti
pathogen
approach
led
identif
new
speci
arenaviru
patient
suffer
infecti
diseas
caus
pathogen
could
detect
use
avail
diagnost
procedur
palacio
et
al
similarli
novel
mcpyv
character
merkel
cell
carcinoma
sampl
recogn
contribut
factor
pathogenesi
feng
et
al
thu
methodolog
suitabl
applic
infecti
pathogen
unknown
current
studi
search
presenc
viru
express
rna
level
human
cll
use
massiv
sequenc
technolog
associ
digit
transcriptom
subtract
method
peripher
blood
sampl
obtain
seven
cll
patient
meet
diagnost
criteria
intern
workshop
chronic
lymphocyt
work
group
hallek
et
al
five
healthi
donor
written
inform
consent
obtain
accord
ethic
regul
uruguay
declar
helsinki
select
cll
patient
diagnos
progress
phenotyp
tabl
peripher
blood
mononuclear
cell
pbmc
isol
centrifug
pharmacia
fine
chemic
uppsala
sweden
immedi
cryopreserv
liquid
nitrogen
total
rna
five
cll
patient
five
healthi
donor
extract
use
rneasi
midi
kit
qiagen
alameda
ca
usa
integr
rna
analys
agil
bioanalys
quantum
analyt
foster
citi
ca
usa
rna
purifi
mrna
purif
kit
invitrogen
carlsbad
ca
usa
two
cdna
sampl
synthes
pool
five
cll
patient
pool
normal
individu
oligo
dt
primer
use
superscript
cdna
synthesi
kit
invitrogen
librari
made
pool
librari
pyrosequenc
one
full
plate
two
plate
total
use
standard
life
scienc
flx
sequenc
chemistri
life
scienc
branford
ct
usa
two
addit
cll
patient
sequenc
individu
purif
popul
perform
flow
cytometri
moflo
cell
sorter
beckman
coulter
inc
brea
ca
usa
phycoerythrin
conjug
monoclon
antibodi
dako
glostrup
denmark
puriti
isol
shown
greater
flow
cytometr
evalu
activ
isol
acet
tpa
dispens
mmoll
stock
solut
dimethyl
sulfoxid
final
concentr
follow
tpa
addit
cll
incub
h
matur
cell
document
increas
mean
cell
volum
characterist
chang
cell
morpholog
total
rna
activ
isol
invitrogen
qualiti
control
perform
previous
describ
librari
prepar
use
slightli
modifi
version
protocol
direct
avail
illumina
illumina
inc
san
diego
ca
usa
normal
use
thermost
nucleas
dsn
evrogen
moscow
russia
perform
cluster
gener
step
normal
base
denatur
dna
librari
follow
addit
dsn
partial
renatur
highli
express
gene
ribosom
rna
trna
gene
rapidli
renatur
form
dna
degrad
dsn
enzym
dna
molecul
deriv
less
abund
transcript
preserv
zhulidov
et
al
bogdanova
et
al
sequenc
conduct
cycl
illumina
genom
analyz
iix
use
one
flowcel
lane
per
librari
base
call
qualiti
score
produc
use
illumina
genom
analyz
softwar
sequenc
filter
trim
appropri
sequenc
technolog
use
case
remov
ribosom
sequenc
read
map
human
genom
transcriptom
refer
download
ucsc
univers
california
santa
cruz
genom
browser
kent
et
al
ensembl
flicek
et
al
databas
remain
read
ie
could
determin
human
origin
screen
blast
basic
local
align
search
tool
altschul
et
al
search
refseq
pruitt
et
al
viral
databas
identifi
put
xenobiot
sequenc
present
step
follow
main
idea
origin
digit
subtract
propos
weber
et
al
introduc
modif
chang
align
tool
order
cope
differ
attribut
sequenc
data
produc
technolog
fig
summar
pipelin
employ
illumina
data
respect
detail
descript
analysi
simul
conduct
given
onlin
supplementari
data
fig
tabl
si
pyrosequenc
result
raw
read
pool
cll
normal
mrna
sampl
respect
fig
trim
filter
step
includ
remov
ribosom
read
read
remain
cll
normal
sampl
respect
cll
averag
length
nucleotid
nt
normal
averag
length
nt
isol
read
present
cll
pool
sampl
initi
search
use
blast
allow
us
discard
cll
read
also
present
normal
sampl
remain
sequenc
sequenti
align
blat
align
tool
kent
human
transcriptom
genom
return
list
candid
read
read
poor
align
signific
match
found
read
viral
databas
recov
align
short
high
fig
though
necessarili
expect
high
similar
align
qualiti
known
viral
agent
care
read
also
display
align
similar
qualiti
human
transcriptom
genom
thu
abl
find
put
sequenc
viral
origin
known
novel
present
cll
pool
sampl
absent
normal
pool
sequenc
limit
approxim
sequenc
cll
transcriptom
sequenc
depth
bioinformat
analysi
suggest
would
insuffici
detect
rare
viral
transcript
see
detail
therefor
decid
studi
two
addit
patient
use
illumina
sequenc
technolog
offer
greatli
increas
depth
expens
shorter
read
length
patient
diagnos
progress
malign
even
igg
case
tabl
two
substanti
improv
dataset
prepar
librari
normal
total
rna
rather
mrna
increas
amount
read
enabl
detect
transcript
low
express
level
furthermor
exclud
possibl
viru
could
integr
genom
bare
transcrib
analys
isol
cell
prior
treatment
potent
protein
kinas
c
pkc
activ
blumberg
illumina
sequenc
yield
million
raw
read
per
sampl
million
read
per
sampl
remain
filter
step
tabl
data
previous
mention
given
larg
amount
sequenc
data
chang
map
tool
final
blast
search
subtract
pipelin
necessari
begin
use
align
bwa
li
durbin
discard
read
human
origin
success
map
ribosom
rna
human
genom
transcriptom
databas
summari
bwa
map
result
tabl
show
ribosom
content
total
rna
librari
figur
compar
ribosom
deplet
protocol
regard
read
align
genom
transcriptom
databas
respect
million
read
remain
unmap
second
phase
unmap
read
first
subject
nucleotid
blast
similar
search
databas
viral
genom
fig
see
data
discuss
blastn
nucleotid
blast
protocol
use
averag
read
per
sampl
match
least
one
viral
genom
tabl
read
thu
consid
initi
candid
viral
read
howev
mani
candid
viral
sequenc
also
match
human
genom
transcriptom
could
mean
linear
discrimin
function
see
data
detail
assign
human
origin
tabl
next
blast
similar
search
perform
unmap
candid
viral
read
read
poor
match
human
posterior
probabl
lower
whole
nucleotid
databas
nt
follow
care
inspect
result
expect
read
higher
similar
mammalian
sequenc
constitut
abund
class
four
sampl
fig
tabl
sii
data
read
match
viral
sequenc
map
primer
bind
site
pb
monkey
viru
mpmv
end
primat
betaretroviru
carri
two
long
termin
repeat
separ
nucleotid
complementari
usual
primer
revers
transcript
viral
genom
sonigo
et
al
analysi
reveal
read
would
sequenc
first
stretch
read
deriv
human
precursor
follow
region
variabl
data
fig
support
absenc
addit
mpmv
read
transcriptom
ie
read
align
mpmv
genom
loci
pb
definit
exclud
true
viral
origin
read
data
read
show
put
viral
origin
also
dismiss
align
viral
genom
qualiti
better
human
classifi
human
linear
discrimin
analysi
lda
although
posterior
probabl
lower
ii
low
complex
repeat
iii
unknown
relat
human
diseas
see
grouper
iridoviru
sindbi
viru
glypta
fumiferana
lausanneviru
isol
onlin
supplementari
data
final
nine
read
one
two
activ
sampl
tabl
data
show
high
similar
viru
genom
ebv
region
gene
case
align
ebv
genom
involv
full
length
read
neither
human
genom
transcriptom
thu
nine
read
consid
true
viral
origin
expect
use
illumina
sequenc
technolog
drastic
increas
transcriptom
depth
reach
comparison
read
count
cll
sampl
show
gene
detect
illumina
respect
ii
gene
present
data
absent
illumina
data
iii
absent
gene
show
count
median
higher
illumina
sampl
fig
data
instanc
gene
absent
data
detect
least
five
read
illumina
sequenc
fulfil
addit
requir
present
least
two
sampl
addit
focus
two
gene
cll
diseas
lpl
specif
gene
known
differenti
express
mutat
unmut
cll
patient
respect
show
opposit
behaviour
oppezzo
et
al
raw
read
count
assay
pool
unmut
patient
could
detect
seven
read
lpl
one
read
meanwhil
illumina
technolog
account
read
lpl
one
read
case
unmut
sampl
mutat
patient
illumina
raw
read
count
one
lpl
respect
notabl
expect
express
ratio
could
detect
illumina
sequenc
demonstr
higher
resolut
method
first
draft
human
genom
enabl
develop
new
techniqu
detect
presenc
foreign
sequenc
human
transcriptom
silico
filter
transcript
refer
genom
weber
et
al
xu
et
al
show
simpl
digit
subtract
approach
success
detect
viral
sequenc
viru
infect
tissu
advent
massiv
parallel
sequenc
technolog
renew
interest
discoveri
novel
pathogen
aros
new
virus
recent
identifi
caus
agent
human
diseas
feng
et
al
palacio
et
al
date
life
scienc
chosen
technolog
discov
new
pathogen
transcriptom
data
mainli
longer
read
length
simplifi
identif
novel
agent
read
detect
howev
illumina
technolog
achiev
increas
read
length
develop
protocol
sequenc
advantag
becom
overpow
impress
amount
sequenc
data
produc
illumina
genom
analyz
hiseq
sequenc
least
case
foreign
agent
expect
weakli
express
sampl
librari
respect
illumina
sequenc
pair
digit
subtract
strategi
recent
shown
sensit
enough
mine
librari
decreas
amount
spike
moor
et
al
recent
small
rna
illumina
sequenc
also
prove
suitabl
discov
virus
plant
insect
strategi
base
small
interf
rna
sirna
immun
respons
organ
trigger
viru
infect
kreuz
et
al
wu
et
al
et
al
present
caus
factor
firmli
link
aetiolog
cll
common
form
leukaemia
among
caucasian
popul
analys
put
involv
viral
agent
onset
conduct
two
survey
cll
transcriptom
acquir
massiv
parallel
sequenc
technolog
first
appli
digit
subtract
human
sequenc
sequenc
data
rna
pool
five
cll
patient
improv
sensit
prepar
pair
sampl
without
prior
treatment
potent
cell
activ
two
addit
patient
normal
librari
total
rna
sequenc
illumina
technolog
increas
data
yield
sequenc
shown
approach
allow
import
increas
transcript
detect
pronounc
gene
express
low
level
nine
read
viral
origin
ebv
detect
one
activ
sampl
ebv
preval
human
approxim
evid
accumul
far
strongli
support
involv
pathogenesi
wide
spectrum
human
malign
particularli
case
patient
thompson
kurzrock
role
ebv
cll
develop
ebv
infect
demonstr
play
role
case
secondari
malign
gener
involv
new
clone
tsimberid
et
al
dolcetti
carbon
tarrand
et
al
thu
given
avail
data
assign
nine
read
ebv
origin
consid
neither
unexpect
relev
work
retrovirus
first
discov
agent
anim
discoveri
role
adult
cell
leukaemia
confirm
retrovirus
also
oncogen
human
initi
extens
research
retrovir
aetiolog
human
chronic
diseas
cancer
caveat
studi
fact
retrovir
candid
cll
would
detect
use
strategi
show
high
similar
human
endogen
retrovir
herv
sequenc
allow
read
map
human
genom
assembl
analys
voisset
et
al
also
herv
transcrib
relat
cll
would
detect
pipelin
howev
worth
mention
bovin
analog
model
cll
produc
deltaretroviru
blv
herv
relat
deltaretrovirus
expect
specif
face
confound
factor
furthermor
singl
except
hiv
htlv
role
retrovirus
human
diseas
remain
highli
controversi
voisset
et
al
weiss
instanc
last
rna
rumour
virus
xenotrop
murin
leukaemia
viru
seem
erron
relat
diseas
consequ
contamin
artefact
robinson
et
al
simmon
et
al
conclus
despit
analys
cll
transcriptom
seven
differ
patient
massiv
parallel
sequenc
technolog
provid
depth
need
detect
put
viral
agent
fail
identifi
candid
viral
sequenc
although
search
conduct
two
power
technolog
data
definit
exclud
viral
origin
human
cll
exist
novel
viru
suffici
distant
sequenc
relat
agent
would
difficult
detect
given
studi
includ
limit
number
patient
exclud
infecti
agent
could
found
small
percentag
patient
exclud
possibl
viru
could
oper
hit
run
agent
also
infecti
agent
might
oper
indirectli
attack
microenviron
cell
studi
genom
level
might
requir
definit
exclud
presenc
integr
retroviru
truli
interest
novel
concept
would
popul
genom
studi
design
explor
potenti
role
polymorph
herv
aetiolog
factor
cll
sb
pm
hp
perform
experi
nr
hn
conduct
bioinformat
analysi
ak
hp
ap
contribut
analysi
sb
po
cr
gd
op
design
studi
gd
op
coordin
studi
author
involv
analysi
interpret
result
author
read
gave
comment
approv
final
version
manuscript
author
report
potenti
conflict
interest
